AIDS vaccine focus shifts after disappointments

WASHINGTON (Reuters) - A global AIDS vaccine conference this week will seek fresh strategies against the HIV virus, with experts weighing the value of basic laboratory research against large-scale human clinical trials after a string of disappointments.

Read the whole article on Reuters:Science

More from Reuters:Science